ArticleClinical ophthalmology (Auckland, N.Z.)2026
Perfluorodecalin and Viscoelastic-Assisted Internal Limiting Membrane Flap Technique for High Myopia Macular Hole Retinal Detachment.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the feasibility and outcomes of a novel surgical technique using a sub-perfluorodecalin (PFD, RT DECALIN) injection of ophthalmic viscosurgical device (OVD) to stabilize inverted internal limiting membrane (ILM) flaps for the treatment of macular hole retinal detachment (MHRD) in highly myopic eyes. This technique addresses the challenges of ILM flap displacement and stability. Patients and Methods: This retrospective, interventional case series included seven eyes of seven patients with MHRD who underwent surgery using sub-PFD injection of OVD to stabilize inverted ILM flaps. Pre- and postoperative best-corrected visual acuity (BCVA) was compared using the Wilcoxon signed-rank test. Ethical approval was obtained, and all patients provided informed consent. Fundus color photography and optical coherence tomography (OCT) were used to assess anatomical outcomes. Results: The study included seven eyes of seven patients (mean age: 61.86±4.30 years; follow-up: 6 months). All eyes achieved successful macular hole closure, with near-normal foveal contour observed in five (71.43%) eyes at the final follow-up. BCVA improved significantly from 2.03±0.38 logMAR to 1.20±0.54 logMAR (P = 0.0024). No intraoperative or postoperative complications were observed. Conclusion: Sub-PFD injection of OVD for stabilization of the inverted ILM flap was feasible and was associated with favorable short-term anatomical outcomes in highly myopic eyes with MHRD. Improvement in BCVA was also observed during follow-up. This innovative approach offers a promising solution to the challenges associated with MHRD in highly myopic eyes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.